Toggle navigation
Home
Search
Services
Blog
Contact
About
Phase II/III Trial-Sildenafil for Sickle Cell Disease-Assoc. Pulm. Hypertension
Search grants from
Share this grant:
:
:
Abstract
Funding
Related projects
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Basic Mechanisms in Hearing Loss of Cochlear Origin
Effectiveness Of Tailored Activity Pacing For Symptomatic Osteoarthritis
Cloning & Regulation of the Maxi-K+Channel in Mtal
Effect of Maternal Diet on Body Odors & Infant Behavior
Severely Mentally Ill Members of Health Maintenance Organizations
Recently added grants:
Ultra-fast high-resolution imaging of whole mouse brain for the study of drug addiction
Function of V-ATPases in Breast Cancer Metastasis
BLRD Research Career Scientist Award Application
Blrd Research Career Scientist Award Application
Strategic Molecular Activations for the Selective Synthesis of 2-Deoxy-Beta-Glycosides, and for the Synthesis of Novel Donor-Acceptor Stenhouse Adducts
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research and Development Contracts (N01)
Project #
N01HB67190-2-0-1
Application #
7574870
Study Section
Project Start
2006-09-30
Project End
2009-12-31
Budget Start
Budget End
Support Year
Fiscal Year
2007
Total Cost
Indirect Cost
Related projects
NIH 2008
N01 HL
Phase II/III Trial-Sildenafil for Sickle Cell Disease-Assoc. Pulm. Hypertension
/ Albert Einstein College of Medicine
$396,788
NIH 2007
N01 HL
Sildenafil for Sickle Cell Disease-Associated Pulmonary Hypertension
Little, Jane /
$471,185
NIH 2007
N01 HL
Phase II/III Trial-Sildenafil for Sickle Cell Disease-Assoc. Pulm. Hypertension
/
NIH 2007
N01 HL
/
Comments
Be the first to comment on this grant